Prevention of crescentic glomerulonephritis induced by anti-glomerular membrane antibody in tumor necrosis factor-deficient mice

Citation
M. Le Hir et al., Prevention of crescentic glomerulonephritis induced by anti-glomerular membrane antibody in tumor necrosis factor-deficient mice, LAB INV, 78(12), 1998, pp. 1625-1631
Citations number
23
Categorie Soggetti
Medical Research General Topics
Journal title
LABORATORY INVESTIGATION
ISSN journal
00236837 → ACNP
Volume
78
Issue
12
Year of publication
1998
Pages
1625 - 1631
Database
ISI
SICI code
0023-6837(199812)78:12<1625:POCGIB>2.0.ZU;2-B
Abstract
Tumor necrosis factor (TNF) is a proinflammatory cytokine playing a central role in the expression of endothelial adhesion molecules required for the recruitment of inflammatory cells. Proliferative glomerulonephritis induced by anti-glomerular basement membrane (GBM) antibody is characterized by th e recruitment of inflammatory cells in the glomerulus followed by capillary damage and crescent formation. The glomerular pathology may be due to a la rge extent to TNF induction. We therefore tested this hypothesis in TNF-def icient mice. Anti-GBM antibody administration in sensitized wild-type mice resulted in deposition of immune complexes, followed by increased intercell ular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VC AM-1) expression, as well as the influx of polymorphonuclear neutrophils (P MNs), lymphocytes, and macrophages. Distinct proteinuria preceded prolifera tive glomerulonephritis characterized by crescent formation. In the absence of TNF, the development of proteinuria was delayed and the formation of cr escents was almost completely prevented. Although the deposition of immune complexes in glomeruli was comparable in both groups, the up-regulation of ICAM-1 and VCAM-1, as well as the influx of PMNs and lymphocytes, but not o f monocytes, was dramatically reduced in TNF-deficient mice. Therefore, we conclude that TNF plays a key role in the recruitment of inflammatory cells and in the subsequent development of proliferative glomerulonephritis.